Purpose
Evidence suggests that aberrant glutamatergic-signalling plays a role in numerous psychopathologies. To ascertain the mechanisms of neuropsychiatric illnesses and their treatment, accurate and reliable imaging techniques are required; proton magnetic resonance spectroscopy (1H-MRS) can non-invasively measure glutamatergic function. Until recently, overlapping glutamatergic signals (glutamate, glutamine, and glutathione) could not easily be separated. However, the advent of novel pulse sequences and higher field magnetic resonance imaging (MRI) allows more precise resolution of overlapping glutamatergic signals, although the question of signal reliability remains undetermined.
Materials and Methods
At 7 T MR, we acquired 1H-MRS data from the medial pregenual anterior cingulate cortex of healthy volunteers (N = 26) twice on two separate days. An adapted echo time optimised point resolved spectroscopy sequence, modified with the addition of a J-suppression pulse to attenuate N-acetyl-aspartate multiplet signals at 2.49 parts per million, was used to excite and acquire the spectra. In house software was used to model glutamate, glutamine, and glutathione, amongst other metabolites, referenced to creatine. Intraclass correlation coefficients (ICCs) were computed for within- and between-session measurements.
Results
Within-session measurements of glutamate, glutamine, and glutathione were on average reliable (ICCs ≥ 0.7). As anticipated, ICCs for between-session values of glutamate, glutamine, and glutathione were slightly lower but nevertheless reliable (ICC > 0.62). A negative correlation was observed between glutathione concentration and age (r(24) = −0.37; P < .05), and a gender effect was noted on glutamine and glutathione.
Conclusion
The adapted sequence provides good reliability to measure glutamate, glutamine and glutathione signals.